IndyGeneUS Continues to Drive Health Innovation with Latent Knowledge's Advanced AI Technology

New software supercharges the discovery and development of equitable, high-quality medical therapeutics at IndyGeneUS.
By: IndyGeneUS AI
 
WASHINGTON - Nov. 6, 2023 - PRLog -- IndyGeneUS AI adds Latent Knowledge to its roster of AI innovation partners to power its Precision Health Discovery (PHD) platform, which makes decentralized clinical trials (DCT) research possible through federated data architecture.

Latent Knowledge, a search and knowledge management company, is positioning LitView, its AI search engine, as a means of bringing together disconnected data sources to validate and share a more agile and effective user experience.

As IndyGeneUS collects genomic data and discovers unique gene variants, LitView adds literature-based discovery (LBD) capabilities to help facilitate all research innovations established on the IndyGeneUS PHD platform.

"The current drug development and clinical research landscape is a disconnected ecosystem of literature and patent databases, experimental data, regulatory bottlenecks, and siloed repositories across R&D enterprises," said Yusuf Henriques, CEO & Founder of IndyGeneUs AI. "Utilizing LitView, expedites the linkage of genetic data housed on the PHD to scientific literature."

Users of LitView's private beta program, comprised of over 250 global researchers, found articles they couldn't locate on traditional databases using the same keywords and search strategies around drug delivery, public health, mechanical engineering, and entrepreneurship.

"We're excited by the opportunity to work with IndyGeneUS AI as their search and knowledge management partner and contribute to their health equity initiatives with literature based discovery technology," says James Reilly, Latent Knowledge CEO and co-founder.

To support IndyGeneUS AI, LitView will enable literature-based discovery of new and relevant literature around related pathways, biosimilars, alternative treatments, and multidisciplinary innovations to support novel therapeutics.

To learn more about IndyGeneUS visit: https://indygeneus.ai or to learn more about LitView visit: https://www.litview.co. Please direct media inquiries to Angel Livas - angel@indygeneus.ai

IndyGeneUS AI bio

IndyGeneUS AI, a Black and Veteran-owned artificial intelligence-powered digital health company accelerating the discovery, development, and manufacturing of advanced therapeutics to address health disparities impacting African diaspora populations in accessing equitable, precision healthcare.

Latent Knowledge

Latent Knowledge is a search and knowledge management company. Our flagship product, LitView, is a research project manager and search engine for R&D teams that can organize relevant documents and collaborators across disparate stakeholder ecosystems.

Media Contact
IndyGeneUS AI
angel@indygeneus.ai
End
Source:IndyGeneUS AI
Email:***@indygeneus.ai Email Verified
Tags:Genomics
Industry:Science
Location:Washington - District of Columbia - United States
Subject:Partnerships
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
DC Media Connection News
Trending
Most Viewed
Daily News



Like PRLog?
9K2K1K
Click to Share